Puma Biotechnology

PBYI

Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.

Puma Biotechnology has been a target of short sellers for a while. The current short interest of 8.28% is roughly at the average of the last 12 months (7.28%).